Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Wise

Showing results (321-330 of 361) with videos related to

Pageof 37
Sort By:
Journal of Medicinal Chemistry|August 2, 1996
Aryl 1-but-3-ynyl-4-phenyl-1,2,3,6-tetrahydropyridines as potential antipsychotic agents: synthesis and structure-activity relationshipsS A Glase, H C Akunne, T G Heffner, et al.
Southern Medical Journal|November 1, 1991
Dynamic stereotactic radiosurgery using a linear acceleratorC Worthington, J M Jenrette, J O Fenn, et al.
International Journal of Clinical Pharmacology and Therapeutics|June 3, 2014
Modeling and simulations to confirm a controlled hypoglycemic stress test in healthy subjects is not associated with clinically significant QT prolongationsLai San Tham, Crystal Mei Fen Zhao, Fanni Natanegara, et al.
British Journal of Clinical Pharmacology|July 6, 2007
Atomoxetine pharmacokinetics in healthy Chinese subjects and effect of the CYP2D6*10 alleleYi M Cui, Choo H Teng, Alan X Pan, et al.
Journal of Medicinal Chemistry|December 22, 1995
Identification, characterization and pharmacological profile of three metabolites of (R)-(+)-1,2,3,6-tetrahydro-4-phenyl-1-[(3-phenylcyclohexen-1- yl)methyl]pyridine (CI-1007), a dopamine autoreceptor agonist and potential antipsychotic agentJ L Wright, D M Downing, M R Feng, et al.
Antimicrobial Agents and Chemotherapy|April 28, 2005
Clinical pharmacokinetics of alamifovir and its metabolitesClark Chan, Eyas Abu-Raddad, Georg Golor, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|July 11, 2012
Improving preterm ophthalmologic care in the era of accountable care organizationsC Jason Wang, Alison A Little, Karen Kamholz, et al.
Scientific Reports|October 24, 2015
In vivo optical modulation of neural signals using monolithically integrated two-dimensional neural probe arraysYoojin Son, Hyunjoo Jenny Lee, Jeongyeon Kim, et al.
Journal of Medicinal Chemistry|October 11, 1996
Affinity for dopamine D2, D3, and D4 receptors of 2-aminotetralins. Relevance of D2 agonist binding for determination of receptor subtype selectivityL A van Vliet, P G Tepper, D Dijkstra, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|April 22, 2022
HectoSTAR μLED Optoelectrodes for Large-Scale, High-Precision In Vivo Opto-ElectrophysiologyMihály Vöröslakos, Kanghwan Kim, Nathan Slager, et al.
Pageof 37

Showing results (321-330 of 361) with videos related to

Sort By:
Pageof 37
Journal of Medicinal Chemistry|August 2, 1996
Aryl 1-but-3-ynyl-4-phenyl-1,2,3,6-tetrahydropyridines as potential antipsychotic agents: synthesis and structure-activity relationshipsS A Glase, H C Akunne, T G Heffner, et al.
Southern Medical Journal|November 1, 1991
Dynamic stereotactic radiosurgery using a linear acceleratorC Worthington, J M Jenrette, J O Fenn, et al.
International Journal of Clinical Pharmacology and Therapeutics|June 3, 2014
Modeling and simulations to confirm a controlled hypoglycemic stress test in healthy subjects is not associated with clinically significant QT prolongationsLai San Tham, Crystal Mei Fen Zhao, Fanni Natanegara, et al.
British Journal of Clinical Pharmacology|July 6, 2007
Atomoxetine pharmacokinetics in healthy Chinese subjects and effect of the CYP2D6*10 alleleYi M Cui, Choo H Teng, Alan X Pan, et al.
Journal of Medicinal Chemistry|December 22, 1995
Identification, characterization and pharmacological profile of three metabolites of (R)-(+)-1,2,3,6-tetrahydro-4-phenyl-1-[(3-phenylcyclohexen-1- yl)methyl]pyridine (CI-1007), a dopamine autoreceptor agonist and potential antipsychotic agentJ L Wright, D M Downing, M R Feng, et al.
Antimicrobial Agents and Chemotherapy|April 28, 2005
Clinical pharmacokinetics of alamifovir and its metabolitesClark Chan, Eyas Abu-Raddad, Georg Golor, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|July 11, 2012
Improving preterm ophthalmologic care in the era of accountable care organizationsC Jason Wang, Alison A Little, Karen Kamholz, et al.
Scientific Reports|October 24, 2015
In vivo optical modulation of neural signals using monolithically integrated two-dimensional neural probe arraysYoojin Son, Hyunjoo Jenny Lee, Jeongyeon Kim, et al.
Journal of Medicinal Chemistry|October 11, 1996
Affinity for dopamine D2, D3, and D4 receptors of 2-aminotetralins. Relevance of D2 agonist binding for determination of receptor subtype selectivityL A van Vliet, P G Tepper, D Dijkstra, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|April 22, 2022
HectoSTAR μLED Optoelectrodes for Large-Scale, High-Precision In Vivo Opto-ElectrophysiologyMihály Vöröslakos, Kanghwan Kim, Nathan Slager, et al.
Pageof 37